ESSA Pharma Inc. Common Stock

EPIX CA29668H7085

💰
Capitalization
Small-cap

ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

🔗
Website
https://www.essapharma.com
Annual Performance 1
2021 2022 2023 2024 2025
19% -83% 158% -72% 2%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
15
🙍
Insiders
3
Person Price Shares Total Published Completed
Virsik Peter
COO 		6.03
USD 		694
Sold 		4,185
USD 		07/10/2024 07/10/2024
Virsik Peter
COO 		6.00
USD 		694
Sold 		4,164
USD 		09/09/2024 09/09/2024
Virsik Peter
COO 		6.03
USD 		2,082
Sold 		12,554
USD 		03/09/2024 03/09/2024
Virsik Peter
COO 		6.95
USD 		694
Sold 		4,823
USD 		06/05/2024 06/05/2024
Virsik Peter
COO 		7.94
USD 		694
Sold 		5,510
USD 		05/04/2024 05/04/2024
Virsik Peter
COO 		8.98
USD 		694
Sold 		6,232
USD 		05/03/2024 05/03/2024
Virsik Peter
COO 		10.29
USD 		72,782
Sold 		748,927
USD 		06/02/2024 06/02/2024
Virsik Peter
COO 		9.25
USD 		694
Sold 		6,420
USD 		05/02/2024 05/02/2024
Virsik Peter
COO 		10.04
USD 		500
Sold 		5,020
USD 		05/02/2024 05/02/2024
Virsik Peter
COO 		10.01
USD 		1,718
Sold 		17,197
USD 		16/01/2024 16/01/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include ESSA Pharma Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-66% -61% -79% -34% -72% -81% -98%
Last 52W Low 52W High All-Time Low All-Time High β
0.20 0.19 6.23 0.19 95.00
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Virsik Peter 11 819,303.41 74,482.13 05/01/2024 07/10/2024
Berger Franklin M 3 552,935.36 184,311.79 02/11/2023 21/11/2023
Parkinson David Ross 1 21,212.90 21,212.90 14/12/2023 14/12/2023

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.